USPTO trademark

THERAPEUTIC TARGETING (THETA)

AllowedUSPTOWord markClass 5Class 42

"THERAPEUTIC TARGETING (THETA)" is a word mark owned by Korsana Biosciences, Inc., filed at the USPTO on January 13, 2026. It has been allowed and covers classes 5 and 42.

Get this data via the API
Official USPTO record
THERAPEUTIC TARGETING (THETA) trademark as filed
As filed with the USPTO
Status
Allowed
Since October 27, 2026
Filed
January 13, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99591522
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns THERAPEUTIC TARGETING (THETA)

The owner and representative on file with the office.

Owner

Korsana Biosciences, Inc.

Waltham, United States

Representative

Nicole Kinsley

Foley Hoag LLP

Goods and services

What the mark covers

The products and services THERAPEUTIC TARGETING (THETA) is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors; Drug delivery agents consisting of antibodies or antibody fragments, sold as an integral component of pharmaceuticals; Antibodies and antibody fragments for therapeutic purposes; Antibody-drug conjugates for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors; Antibody fragment-drug conjugates for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors

  • Pharmaceutical research and development

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Notification of examiners amendment e-mailed
  7. Examiner's amendment entered
  8. Examiners amendment e-mailed
  9. Examiners amendment -written
  10. Assigned to examiner

4 earlier steps on the official record.

FAQ

About THERAPEUTIC TARGETING (THETA)

Who owns the trademark "THERAPEUTIC TARGETING (THETA)"?

The USPTO trademark "THERAPEUTIC TARGETING (THETA)" (application 99591522) is owned by Korsana Biosciences, Inc.

What is the status of "THERAPEUTIC TARGETING (THETA)"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull THERAPEUTIC TARGETING (THETA) and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b88-eb41-72ac-b5fb-b054fb103374
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b88-eb41-72ac-b5fb-b054fb103374",
  "object": "trademark",
  "mark_text": "THERAPEUTIC TARGETING (THETA)",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99591522",
  "filing_date": "2026-01-13",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Korsana Biosciences, Inc.",
      "entity_id": null
    }
  ]
}